The company’s stock price dropped after it released its first-quarter earnings and lowered its full-year guidance despite an increase in revenue.
Augmedix stock falls 41% after it lowers FY24 revenue guidance
The company’s stock price dropped after it released its first-quarter earnings and lowered its full-year guidance despite an increase in revenue.
